CDRH Bundling Policy Merits “Modest” Expansion – AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
Discrete premarket submissions should be required for reprocessed single-use devices made by different original equipment manufacturers, AdvaMed states in Jan. 22 comments on CDRH's "bundling" policy
You may also be interested in...
MDUFMA Guidance Clarifies Appropriate Bundling Use For Reprocessed SUDs
A Class II special surgical implant device used to implant a Class III device may be bundled in the same premarket approval application, according to an FDA bundling guidance
MDUFMA Guidance Clarifies Appropriate Bundling Use For Reprocessed SUDs
A Class II special surgical implant device used to implant a Class III device may be bundled in the same premarket approval application, according to an FDA bundling guidance
CDRH Reopens Analyte-Specific Reagent Rule, Expanding IVD Oversight
FDA will begin expanding oversight of homebrew in vitro diagnostics with a notice of proposed rulemaking on analyte-specific reagents in the coming weeks